Jan Orwar

Director/Miembro de la Junta en FLUICELL AB .

62 años

Consumer Services

Commercial Services

Health Technology

Perfil

Jan Owe Owesson Orwar was the founder of Cellectricon AB, founded in 2000, where the title held was Director & Chief Scientific Officer.
Dr. Orwar is the founder of Nanoxis AB, founded in 2002, where the title held was Director & Chief Scientific Advisor from 2002 to 2014.
Dr. Orwar is also the founder of Oblique Therapeutics AB. Dr. Orwar is currently Director-Bioeletronics & Bio-Computing Program at Chalmers University of Technology since 2011.
Dr. Orwar is currently Director at Fluicell AB since 2015.
Dr. Orwar is currently Senior Group Leader at Karolinska Institutet.
Former positions include President-Research & Development at Piramal Enterprises Ltd. and Global Vice President-Research & Development at Sanofi AB. Education includes doctorates from Stanford University and the University of Gothenburg.

Cargos activos de Jan Orwar

Empresas	Cargo	Inicio
FLUICELL AB	Director/Miembro de la Junta	01/01/2015
Chalmers University of Technology Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	17/01/2011
Karolinska Institutet Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

Todos los cargos activos de Jan Orwar

Antiguos cargos conocidos de Jan Orwar.

Empresas	Cargo	Fin
Nanoxis AB Nanoxis AB Miscellaneous Commercial ServicesCommercial Services Provides tools and services for membrane protein research	Fundador	11/02/2014
PIRML ENT	Director Técnico/Científico/I+D	-
Sanofi AB Sanofi AB Medical DistributorsDistribution Services Wholesales pharmaceutical products and medical equipment	Director Técnico/Científico/I+D	-
Oblique Therapeutics AB Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties	Director Ejecutivo	-
Cellectricon AB Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery	Fundador	-

Ver el detalle de la experiencia de Jan Orwar.

Formación de Jan Orwar.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Jan Orwar.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	10
Cellectricon AB Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery	Commercial Services
Stanford University Stanford University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Piramal Enterprises Ltd. Piramal Enterprises Ltd. Investment ManagersFinance Provides asset management, loan and housing finance services and manufactures pharmaceuticals	Finance
Karolinska Institutet Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Chalmers University of Technology Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Gothenburg University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nanoxis AB Nanoxis AB Miscellaneous Commercial ServicesCommercial Services Provides tools and services for membrane protein research	Commercial Services
Fluicell AB Fluicell AB BiotechnologyHealth Technology Provides fluid platforms for multi-functional pipettes for cell-based pharmacology research	Health Technology
Sanofi AB Sanofi AB Medical DistributorsDistribution Services Wholesales pharmaceutical products and medical equipment	Distribution Services
Oblique Therapeutics AB Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties	Health Technology